Investor profile
MP Healthcare Venture Management has backed 6 European tech companies across 7 funding rounds between 2011 and 2025, joining rounds totalling €210M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| GlycoEra | Switzerland | 1 | €114M |
| GenKyoTex | Switzerland | 2 | €34M |
| Trimtech Therapeutics | UK | 1 | €29M |
| Rigontec | Germany | 1 | €14M |
| Draupnir Bio | Denmark |
| 1 |
| €12M |
| PharmEnable | UK | 1 | €6.9M |
| Series C |
| €14M |
| 2011-05 |
| Rigontec | Series A | €14M | 2016-09 |
| Draupnir Bio | Seed | €12M | 2024-07 |
| PharmEnable | Seed | €6.9M | 2023-05 |
